Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
House expands Prescription Drug Affordability Board authority to set upper payment limits
Summary
The House approved House Bill 424 to extend the Prescription Drug Affordability Board's authority to set upper payment limits across commercial markets. Supporters said the measure aggregates purchasing power to lower costs; opponents warned of potential market failures and access problems. The bill passed with 94 affirmative votes.
The Maryland House of Delegates on Feb. 20, 2025, passed House Bill 424, extending authority for the Prescription Drug Affordability Board to set upper payment limits that would affect more of the state's commercial insurance market. The clerk recorded 94 affirmative votes and declared the bill passed.
Sponsors and backers argued the bill aggregates the state's purchasing power to lower prescription prices for Marylanders. "At its very basic level, this…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
